Results     11-May-23
Announcements
Orchid Pharma reports consolidated net profit of Rs 59.14 crore in the March 2023 quarter
Sales rise 17.84% to Rs 209.90 crore
Net profit of Orchid Pharma reported to Rs 59.14 crore in the quarter ended March 2023 as against net loss of Rs 6.59 crore during the previous quarter ended March 2022. Sales rose 17.84% to Rs 209.90 crore in the quarter ended March 2023 as against Rs 178.13 crore during the previous quarter ended March 2022.

For the full year,net profit reported to Rs 46.32 crore in the year ended March 2023 as against net loss of Rs 1.95 crore during the previous year ended March 2022. Sales rose 19.00% to Rs 665.90 crore in the year ended March 2023 as against Rs 559.56 crore during the previous year ended March 2022.

ParticularsQuarter EndedYear Ended
 Mar. 2023Mar. 2022% Var.Mar. 2023Mar. 2022% Var.
Sales209.90178.13 18 665.90559.56 19
OPM %18.9014.46 -12.569.50 -
PBDT33.9323.05 47 70.8230.13 135
PBT26.72-3.57 LP 16.03-56.90 LP
NP59.14-6.59 LP 46.32-1.95 LP

Previous News
  Broader mkt underperforms; metal stocks lose shine
 ( Market Commentary - Mid-Session 23-Jun-23   11:35 )
  Orchid Pharma slides as PAT slumps 49% YoY in Q4 FY24
 ( Hot Pursuit - 24-May-24   12:56 )
  Orchid Pharma partners with Cipla to launch antibiotic drug - Cefepime-Enmetazobactam in India
 ( Corporate News - 28-Jun-24   19:23 )
  Orchid Pharma reports consolidated net loss of Rs 5.39 crore in the September 2022 quarter
 ( Results - Announcements 15-Nov-22   08:28 )
  Orchid Pharma to conduct board meeting
 ( Corporate News - 29-Nov-22   10:06 )
  Orchid Pharma update on CIRP
 ( Corporate News - 20-May-19   10:11 )
  Orchid Chemicals & Pharmaceuticals reports net loss of Rs 50.80 crore in the June 2012 quarter
 ( Results - Announcements 14-Aug-12   20:37 )
  Orchid Pharma launches QIP issue
 ( Corporate News - 23-Jun-23   10:12 )
  Orchid Pharma hits the roof on launching QIP issue
 ( Hot Pursuit - 23-Jun-23   11:26 )
  Orchid Chemicals & Pharma to hold committee meeting
 ( Corporate News - 18-Dec-14   14:40 )
  Orchid Pharma receives ANDA approval for Risedronate Sodium Tablets
 ( Corporate News - 14-May-19   16:55 )
Other Stories
  Emerald Finance consolidated net profit rises 98.84% in the June 2024 quarter
  05-Jul-24   15:52
  Kronox Lab Sciences standalone net profit rises 140.98% in the March 2024 quarter
  29-Jun-24   07:31
  Performance Chemiserve standalone net profit rises 6062.22% in the March 2024 quarter
  27-Jun-24   07:24
  Sundew Properties standalone net profit rises 119.15% in the March 2024 quarter
  27-Jun-24   07:24
  IKF Home Finance standalone net profit rises 42.15% in the March 2024 quarter
  27-Jun-24   07:24
  Delhi Transco standalone net profit rises 1.08% in the March 2024 quarter
  27-Jun-24   07:24
  Profectus Capital Pvt standalone net profit rises 12.12% in the March 2024 quarter
  27-Jun-24   07:24
  Shrem Infra Invest Pvt consolidated net profit rises 290.12% in the March 2024 quarter
  27-Jun-24   07:24
  Bharat Ekansh reports consolidated net loss of Rs 0.01 crore in the March 2024 quarter
  27-Jun-24   07:24
  Patel KNR Heavy Infrastructures reports standalone net loss of Rs 2.71 crore in the March 2024 quarter
  27-Jun-24   07:24
Back Top